Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
PIK3CA-Related Overgrowth Spectrum (PROS)
Shanghai, Shanghai Municipality
PIK3CA-Related Overgrowth Spectrum (PROS) Clinical Trials in Shanghai, Shanghai Municipality
1 recruiting
Shanghai, Shanghai Municipality, China
Showing
1–1
of
1
trials
Recruiting
Phase 1
Phase 2
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM)
PIK3CA-Related Overgrowth Spectrum (PROS)
PIK3CA-related Vascular Malformations (PRVM)
Haihe Biopharma Co., Ltd.
141 enrolled
4 locations
NCT06975618
Feedback